Credentialing
|
Cancer and Leukemia Group B (CALGB)
|
|
|
For credentialing inquiries…” replace with: At the present time the IROC Houston is not credentialing for any CALGB protocols. For all other inquiries please visit the IROC Houston website
|
30609
|
-
|
A RANDOMIZED PHASE III COMPARISON OF STANDARD- DOSE (60 Gy) VERSUS HIGH-DOSE (74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND CONSOLIDATION CARBOPLATIN/PACLITAXEL IN PATIENTS WITH STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER--(CLOSED)
|
|
31102
|
-
|
Phase I study of Accelerated Hypofractionated Radiation Therapy with Concomitant chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer. --Closed (1/5/2015)
|
|
80803
|
-
|
Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer --Closed(5/11/2015)
|
|
50801
|
-
|
Phase II Trial of response-adapted Therapy Based On Positron Emission Tomography (PET) for Bulky Stage I And Stage II classical Hodgkin Lymphoma (HL)
- Closed (10/17/2017)
|
|
30610
|
-
|
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
-Closed(12/01/2019)
|